Hein F.M. Lodewijkx and Arjan E.R. Bos. Lance Armstrong’s Era of Performance — Part II: Revisiting His Time Trial Wins.
. 2014; 2(5):194-201. doi: 10.12691/AJSSM-2-5-4
doping, professional cycling, time trial performance
This work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit
[1] | A. Dilger, B. Frick and F. Tolsdorf, “Are athletes doped? Some theoretical arguments and empirical evidence”, Contemporary Economic Policy, 25 (4), 604-615, 2007. |
|
[2] | W. Voet, Breaking the chain, London, Yellow Jersey Press / Random House, 2001. |
|
[3] | T. Hamilton and D. Coyle, The secret race, New York, Bantam Books, 2012. |
|
[4] | USADA, Statement from USADA CEO Travis T. Tygart regarding the U.S. Postal Service Pro Cycling Team doping conspiracy, 2012. Available http://cyclinginvestigation.usada.org |
|
[5] | USADA, Reasoned decision of the United States Anti–Doping Agency on disqualification and ineligibility, 2012. Available http://cyclinginvestigation.usada.org |
|
[6] | H. F.M. Lodewijkx and P. Verboon, “Lance Armstrong’s era of performance – Part I: Are his time trial performances much different from other winners?”, Journal of Athletic Enhancement, 2 (1), 2013. |
|
[7] | T. V. Perneger, “Speed trends of major cycling races: Does slower mean cleaner?”, International Journal of Sports Medicine, 31, 261-264, 2010. |
|
[8] | H. Vandeweghe, Who has faith in cyclists anymore? [In Dutch: Wie gelooft de coureurs nog?], Ghent (Belgium), Borgerhoff and Lamberigts, 2013. |
|
[9] | R. T. Carroll, The skeptic's dictionary: A collection of strange beliefs, amusing deceptions, and dangerous delusions, Hoboken (NJ), John Wiley and Sons, 2003. |
|
[10] | N. El Helou, G. Berthelot, V. Thibaut, M. Tafflet, H. Nassif, F. Campion., …J.-F. Toussaint, “Tour de France, Giro, Vuelta, and classic European races show a unique progression of road cycling speed in the last 20 years”, Journal of Sports Sciences, 28 (7), 789-796, 2010. |
|
[11] | H. F. M. Lodewijkx, “Lance Armstrong’s era of performance – Part III: Demonstrating the post hoc fallacy”, American Journal of Sports Science and Medicine, 1 (4), 63-70, 2013. |
|
[12] | H. F. M. Lodewijkx and B. Brouwer, “Some empirical notes on the ‘epo epidemic’ in professional cycling”, Research Quarterly for Exercise and Sport, 82 (4), 593-608, 2011. |
|
[13] | H. F. M. Lodewijkx and B. Brouwer, “Tour, Giro, Vuelta: Rapid progress in cycling performance starts in the 1980s”, International Journal of Sports Science, 2 (3), 24-31, 2012. |
|
[14] | WADA. World Anti-Doping Agency Prohibited list, 2013. Available http://www.wada-ama.org/en/World-Anti-Doping-Program/Sports-and-Anti-Doping-Organizations/International-Standards/Prohibited-List/. |
|
[15] | D. Magnier, P. Picq, M. Debreilly, P. Zingoni, H. Haffreingue, and J.–L Bey, Cycling remembered. [In French: Mémoires du cyclisme], 2013. Available http://www.memoire–du–cyclisme.eu. |
|
[16] | A. Lucia, C. Earnest and C. Arribas, “The Tour de France: a physiological review”, Scandinavian Journal of Medicine and Science in Sports, 13, 275-283, 2003. |
|
[17] | H. F. M. Lodewijkx and P. Verboon, “The Texas sharpshooter in the three Grand Tours (1933-2013): No evidence for superior time trial performances in the epo era”, Manuscript submitted for publication, Breda (the Netherlands), Open University of the Netherlands, 2014. |
|
[18] | A. F. Hayes, “INDIRECT: An SPSS-macro for estimating indirect path coefficients in regression models”, 2013. Available http://afhayes.com/spss-sas-and-mplus-macros-and-code.html\. |
|
[19] | K. J. Preacher and A. F. Hayes, “Asymptotic and resampling strategies for assessing and comparing indirect effects in multiple mediator models”, Behavior Research Methods, 40, 879-891, 2008. |
|
[20] | B.G. Tabachnick and L.S. Fidell, Using multivariate statistics (4th ed.), Boston, Allyn and Bacon / Pearson Education Company, 2001. |
|
[21] | H. Verbruggen, “The EPO epidemic in sport”, Bloodline Reviews, 1, 3-4, 2001. |
|
[22] | H. Kuipers, “Putative effects of doping in cycling” [In Dutch: “Vermeende effecten van doping in de wielersport”], Nederlands Tijdschrift voor Geneeskunde, 150, 2643-2645, 2006. |
|
[23] | C. Lundby, C. and N.V. Olsen, “Effects of recombinant human erythropoietin in normal humans”, Journal of Physiology, 589, 1265-1271, 2011. |
|
[24] | J. R. Bytomski, C. T. Moorman III and D. MacAuley, Oxford American handbook of sports medicine, Oxford, Oxford University Press, 2010. |
|
[25] | C. Lundby, P. Robach and B. Saltin, “The evolving science of detection of ‘blood doping’ ”, British Journal of Pharmacology, 165, 1306-1315, 2012. |
|
[26] | H. F. M. Lodewijkx, B. Brouwer, H. Kuipers and R. van Hezewijk, “Overestimated effect of epo administration on aerobic exercise capacity: A meta–analysis”, American Journal of Sports Science and Medicine, 1 (2), 17-27, 2013. |
|
[27] | J. A. A. C. Heuberger, J. M. Cohen–Tervaert, F. M. L. Schepers, A. D. B. Vliegenthart, J. I. Rotmans, J. Daniels … A. F. Cohen, “Erythropoietin doping in cycling: Lack of evidence for efficacy and a negative risk–benefit”, British Journal of Clinical Pharmacology, 75 (6), 1406-1421, 2013. |
|
[28] | D. H. Catlin, C. K. Hatton and F. Lasne, Abuse of recombinant erythropoietins by athletes. In G. Moulineux, M. A. Foote and S. G. Elliott (Eds.) Erythropoietins and erythropoiesis, Basel, Birkhäuser Verlag, 2006, 205-228. |
|
[29] | B. F. Brewer, “Commercialization in professional cycling 1950-2001: Institutional transformations and the rationalization of doping”, Sociology of Sport Journal, 19, 276-301, 2002. |
|
[30] | W. Fotheringham, Fallen angel: The passion of Fausto Coppi, London, Yellow Jersey Press, 2009. |
|
[31] | B. Maso, The sweat of the Gods, Norwich (UK), Mousehold Press, 2005. |
|